Inhibiting hypoxia-inducible factor 1 for cancer therapy
about
SIRT2 regulates tumour hypoxia response by promoting HIF-1α hydroxylationMitochondria, cholesterol and cancer cell metabolismHypoxia-inducible aryl hydrocarbon receptor nuclear translocator (ARNT) (HIF-1β): is it a rare exception?Dietary administration of scallion extract effectively inhibits colorectal tumor growth: cellular and molecular mechanisms in miceOptical imaging probes in oncologyParadoxical regulation of hypoxia inducible factor-1α (HIF-1α) by histone deacetylase inhibitor in diffuse large B-cell lymphomaPrognostic significance of Hypoxia-Inducible Factor 1 alpha(HIF-1 alpha) expression in serous ovarian cancer: an immunohistochemical studyIdentification of a novel small molecule HIF-1alpha translation inhibitor.Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.Biological characteristics of prostate cancer cells are regulated by hypoxia-inducible factor 1αHypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents.Negative regulation of hypoxic responses via induced Reptin methylation.Dual inhibition of plasminogen kringle 5 on angiogenesis and chemotaxis suppresses tumor metastasis by targeting HIF-1α pathway.From antiangiogenesis to hypoxia: current research and future directions.A cyclic peptide inhibitor of HIF-1 heterodimerization that inhibits hypoxia signaling in cancer cells.HIF2alpha inhibition promotes p53 pathway activity, tumor cell death, and radiation responses.Andrographolide inhibits hypoxia-inducible factor-1 through phosphatidylinositol 3-kinase/AKT pathway and suppresses breast cancer growth.Integrin beta-8 (ITGB8) silencing reverses gefitinib resistance of human hepatic cancer HepG2/G cell line.Hypoxia, stem cells and bone tumorDesign and synthesis of novel small-molecule inhibitors of the hypoxia inducible factor pathwayMetabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy.Requirement of evading apoptosis for HIF-1α-induced malignant progression in mouse cells.Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells.Neutralizing S1P inhibits intratumoral hypoxia, induces vascular remodelling and sensitizes to chemotherapy in prostate cancer.MicroRNA-454 regulates stromal cell derived factor-1 in the control of the growth of pancreatic ductal adenocarcinomaHypoxia inducible factor-1alpha inactivation unveils a link between tumor cell metabolism and hypoxia-induced cell death.Macrophage migration inhibitory factor manipulation and evaluation in tumoral hypoxic adaptation.Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies.Design and in vitro activities of N-alkyl-N-[(8-R-2,2-dimethyl-2H-chromen-6-yl)methyl]heteroarylsulfonamides, novel, small-molecule hypoxia inducible factor-1 pathway inhibitors and anticancer agents.MFTZ-1 reduces constitutive and inducible HIF-1α accumulation and VEGF secretion independent of its topoisomerase II inhibition.Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.Bioengineering approaches to study multidrug resistance in tumor cells.Flavonoids, a ubiquitous dietary phenolic subclass, exert extensive in vitro anti-invasive and in vivo anti-metastatic activities.The Impact of the "Yogic Lifestyle" on Cancer Prognosis and Survival: Can we Target Cancer Stem Cells with Yoga?Neuronal cell fate decisions: O2 and CO2 sensing neurons require egl-13/Sox5.The expression level of the transcription factor Aryl hydrocarbon receptor nuclear translocator (ARNT) determines cellular survival after radiation treatment.LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling.Hypoxia-targeting by tirapazamine (TPZ) induces preferential growth inhibition of nasopharyngeal carcinoma cells with Chk1/2 activation.
P2860
Q24293305-F9E4C151-7B84-466F-A812-60B8313A9B89Q26741708-456CB29F-14DE-49B6-916D-0895398AC167Q27027475-14FB9679-22E5-4CA0-AED4-400E8525584CQ27319843-F39BE5D1-01E0-43B3-B5A0-51500480F0B5Q28067824-1F6DC624-1F44-4976-AB2E-4F2D25DB0B5AQ28535447-210E3C12-6292-4622-9F47-83D125D5EE07Q33384970-7D897447-D65A-49BC-A073-137C1F70B131Q33507488-C6A60921-69F2-4D0E-9B1E-F676197193C9Q33557565-3DEF2151-68B5-437D-B2DF-9C7CE2940265Q33852396-6B8B823C-C054-458B-81E7-254DCCC890C8Q33967632-92246F72-649B-47DB-B10C-C836DA0CD725Q34107629-D9BDAE6D-2CB9-44D7-BB33-B2F2F565BBADQ34122191-A7F60E29-B3F4-4757-9B0E-A4976014C1D3Q34124364-FEC101AC-42A9-47E1-B9F9-8AB8B2D86A82Q34541713-96223DB9-7032-40D0-A2BD-DAFC468F6FC8Q34621100-C8AD7850-7B9E-47E5-9393-099E0B9D5BEDQ34782024-5E239061-63AF-4B92-A2A3-738F29AD015AQ34999383-804BB5A8-21EC-481B-9F6A-9E3F2C7D1BCEQ35105163-E228266E-D491-47A9-ACD1-CE0E60EDE999Q35482150-D123EA3B-0106-4C58-B5E2-DF2678059830Q35549238-FDE445F4-FC4B-438C-883C-4A2654A1F1DDQ35799673-84B270D8-F4AB-4FB7-BD5E-274B366E092BQ35839644-0A6B0528-2F22-4718-BA9D-584CEFB9B133Q35878522-4BC2925D-9E8D-419A-B834-EFEFBD2AE10DQ35880778-80A0F18D-B699-4B0C-AB7D-2EB96104902AQ35955451-B2CC6436-098C-43FF-B2AE-ADBCEE6EDAF5Q36687916-E31D1157-934B-4589-81B3-E87D7AE076B7Q36891578-55E59F78-4A8E-4628-8D97-7D6E4F7F8322Q36999094-8DD2582E-E15E-4C19-916E-E7891B502749Q37051022-6D296FD0-62BC-42C0-A8ED-E9214024BF63Q37130170-5C600A4A-2788-4A63-B37B-26CA94CDF696Q37293931-95CFA3E1-01E7-4C9A-9817-C7F2183ACCF7Q37349436-55C48A77-37D8-483E-9849-8D7D4302B225Q37851027-ECDD94C0-286F-4741-929E-3EC5CA4F5A88Q37982235-22E07687-77A8-4F68-9ACD-316D2ABB8722Q38678683-9EDF41E9-8AED-4EE0-9D04-E9114CCB855AQ38775274-1A17E7CC-E260-403D-94FE-4CB6F434CAB3Q38819393-9DFD5197-DE6A-4D88-951F-824917491DD6Q38912642-40A9C882-7B10-4B83-B8E5-16217EE1C9F6Q39762897-C96A8237-3D57-4DBD-93A4-6F9CC9B1C448
P2860
Inhibiting hypoxia-inducible factor 1 for cancer therapy
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@ast
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@en
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@nl
type
label
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@ast
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@en
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@nl
prefLabel
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@ast
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@en
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@nl
P3181
P1476
Inhibiting hypoxia-inducible factor 1 for cancer therapy
@en
P2093
Giovanni Melillo
P3181
P356
10.1158/1541-7786.MCR-06-0235
P407
P577
2006-09-01T00:00:00Z